Cargando…

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study

There are limited data on therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) patients treated with vedolizumab (VDZ). Although an exposure–response relation has been demonstrated in the post-induction phase, this relationship is more uncertain in the maintenance phase of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivridaş, Merve, Creemers, Rob H., Wong, Dennis R., Boekema, Paul J., Römkens, Tessa E. H., Gilissen, Lennard P. L., van Bodegraven, Adriaan A., Loeff, Floris C., Rispens, Theo, Derijks, Luc J. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051381/ https://www.ncbi.nlm.nih.gov/pubmed/36986833 http://dx.doi.org/10.3390/pharmaceutics15030972

Ejemplares similares

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency
por: Deben, Debbie S., et al.
Publicado: (2023)

A Systematic Review on Long-Term Efficacy Outcome Measures in Crohn’s Disease Patients
por: Janssen, Laura M, et al.
Publicado: (2023)

Vedolizumab for induction and maintenance of remission in Crohn's disease
por: Hui, Samuel, et al.
Publicado: (2023)

Immunogenicity of TNF-Inhibitors
por: Atiqi, Sadaf, et al.
Publicado: (2020)

Acute gastric volvulus: A vicious twist of tummy-case report
por: Kumar, Basudev, et al.
Publicado: (2016)

Earplug Umbilicoplasty: A Simple Method to Prevent Umbilical Stenosis in a Tummy Tuck
por: Kachare, Swapnil, et al.
Publicado: (2019)

Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
por: Derikx, Lauranne A A P, et al.
Publicado: (2020)

Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
por: Volkers, Adriaan, et al.
Publicado: (2022)

Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
por: Perez-Pardo, Paula, et al.
Publicado: (2017)

Awake prone positioning in COVID-19: is tummy time ready for prime time?
por: Weatherald, Jason, et al.
Publicado: (2021)

Randomized Controlled Trial of an Early Child Obesity Prevention Intervention: Impacts on Infant Tummy Time
por: Gross, Rachel S., et al.
Publicado: (2017)

Safe Tummy Tuck: Anatomy and Strategy to Avoid Injury to the Lateral Femoral Cutaneous Nerve During Abdominoplasty
por: Chowdhry, S., et al.
Publicado: (2015)

Objective measurement of tummy time in infants (0-6 months): A validation study
por: Hewitt, Lyndel, et al.
Publicado: (2019)

Abdominal Flap Necrosis and Wound Dehiscence following a Medical Tourist Tummy Tuck
por: Zhitny, Vladislav Pavlovich, et al.
Publicado: (2020)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada
por: Fenu, Elisabetta, et al.
Publicado: (2022)

My tummy hurts – a case report of abdominal pain and macrocytic anemia caused by hypothyroidism
por: Hamid, Kewan, et al.
Publicado: (2018)

Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay
por: Vande Casteele, Niels, et al.
Publicado: (2023)

“I Am Afraid of Positioning my Baby in Prone”: Beliefs and Knowledge about Tummy Time Practice
por: e Silva, Bianca Fernandes Vasconcelos, et al.
Publicado: (2023)

Split Tummy Exercise Program for Reducing Diastasis Recti in Postpartum Primigravidae: A Randomized Controlled Trial
por: Shohaimi, Suhaila, et al.
Publicado: (2023)

Biased anti-idiotype response in rabbits leads to high-affinity monoclonal antibodies to biologics
por: Großerichter-Wagener, Christina, et al.
Publicado: (2020)

Fingerprick blood samples to measure serum natalizumab concentrations
por: Toorop, Alyssa A, et al.
Publicado: (2022)

“My Tummy Tells Me” Cognitions, Barriers and Supports of Parents and School-Age Children for Appropriate Portion Sizes
por: Eck, Kaitlyn M., et al.
Publicado: (2018)

2720. Uninvited Guests in Tiny Tummies: An Assessment of Multidrug Resistant Organism Gut Colonization in Pediatric Transplant Patients
por: Parzen-Johnson, Simon, et al.
Publicado: (2023)

Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis
por: Hu, Qiong, et al.
Publicado: (2023)

A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients
por: Deben, Debbie S., et al.
Publicado: (2022)

Weekly group tummy time classes are feasible and acceptable to mothers with infants: a pilot cluster randomized controlled trial
por: Hewitt, Lyndel, et al.
Publicado: (2020)

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine
por: Bayoumy, Ahmed B., et al.
Publicado: (2021)

Vedolizumab-Associated Hypereosinophilia and Hepatoxicity
por: De Marco, Davide, et al.
Publicado: (2022)

Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry Study
por: Simsek, Melek, et al.
Publicado: (2023)

Case report: Induction and maintenance of steroid-free remission with vedolizumab in a case of steroid-dependent autoimmune pancreatitis
por: Griebel, Paul, et al.
Publicado: (2023)

Tummy Pain is not often what we Think – Imaging Findings in Uncommon Causes of Abdominal Pain in Children and Adolescents – A Case Series
por: Karanth, Krishna Kiran Somashekar, et al.
Publicado: (2023)

Effect of obesity on vedolizumab response in inflammatory bowel disease
por: Levine, Louis J., et al.
Publicado: (2022)

Vedolizumab in the treatment of Crohn’s disease of the pouch
por: Khan, Freeha, et al.
Publicado: (2018)

Vedolizumab for chronic antibiotic-refractory pouchitis
por: Singh, Amandeep, et al.
Publicado: (2019)

The Early Experience With Vedolizumab in the United States
por: Kochar, Bharati, et al.
Publicado: (2019)

Combination of vedolizumab and immunomodulators in ulcerative colitis
por: Pinton, P
Publicado: (2021)

Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases
por: Yarur, Andres J., et al.
Publicado: (2020)

Abstract 114: Potential Risk Factors for Worsening Abdominal Well-Being after Abdominal Flap Breast Reconstruction: There’s No Such Thing As a Free Tummy Tuck
por: Meyer, Meredith L., et al.
Publicado: (2017)

Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives
por: Smeijsters, Erin H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sfc3nqkjre1k2tre5ok48e8t3v